A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Anticoagulant Citrate Phosphate Dextrose (Cpd) and As-5 Red Cell Preservative (IMUFLEX WB-RP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Removing Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative)

First FDA approval2010-02-26
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema7 entries indexed · 4 visible
What is Anticoagulant Citrate Phosphate Dextrose (Cpd) and As-5 Red Cell Preservative used for?

Anticoagulant Citrate Phosphate Dextrose (Cpd) and As-5 Red Cell Preservative is a this drug class medication tracked in Medicare Part D.

Is there a generic for Anticoagulant Citrate Phosphate Dextrose (Cpd) and As-5 Red Cell Preservative?

No. Anticoagulant Citrate Phosphate Dextrose (Cpd) and As-5 Red Cell Preservative is brand-only with no generic equivalents currently in market.

How much does my plan pay for Anticoagulant Citrate Phosphate Dextrose (Cpd) and As-5 Red Cell Preservative?

NADAC pricing data not currently available for this drug.

Is Anticoagulant Citrate Phosphate Dextrose (Cpd) and As-5 Red Cell Preservative on the FDA shortage list?

No. Anticoagulant Citrate Phosphate Dextrose (Cpd) and As-5 Red Cell Preservative is not currently on the FDA Drug Shortage Database.

3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.